Showing results (951-960 of 3,952) with videos related to
Sort By:
Pageof 396
Journal of Nephrology|July 17, 2026
Prevalence of protein-energy wasting among non-dialytic and dialytic chronic kidney disease patients in Africa: a systematic review and meta-analysisOluseyi Ademola Adejumo, Dapo Suday Oyedepo, Imuetinyan Rashida Edeki, et al.Journal of Nephrology|August 5, 2026
Pediatric hematuria as a gateway to family genetic investigation in type IV collagen nephropathies: experience from a regional cohortJohn Dotis, Antonia Kondou, Athina Ververi, et al.Journal of Nephrology|August 6, 2026
Ultrasound-based peritoneal membrane thickness as a marker of inflammation and technique failure in peritoneal dialysisSaliha Yıldırım, Mesudiye Bulut, Sevim Gönen, et al.Journal of Nephrology|July 13, 2002
Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitoninThomas Sitter, Martin Schmidt, Susanne Schneider, et al.Journal of Nephrology|February 7, 2012
Normal fractional urate excretion identifies hyponatremic patients with reset osmostatLouis J Imbriano, Ekambaram Ilamathi, Nicole M Ali, et al.Journal of Nephrology|August 5, 2026
Histopathologic and clinical spectrum of IgA nephropathy coexisting with other glomerulopathies; addressing the diagnostic challenges. Experience from a tertiary care centerSamuel Pramod Paul, Sanjeet Roy, Smita Mary Matthai, et al.Journal of Nephrology|August 3, 2026
Randomized clinical trials: role of the research nurseMichele Provenzano, Roberta Profiti, Lorena Gandía-Salmerón, et al.Journal of Nephrology|July 20, 2026
Telitacicept treatment for active antibody-mediated rejection after kidney transplantation: a case seriesZiyang Luo, Sijia Liu, Rong Ma, et al.Journal of Nephrology|July 23, 2026
Impact of HIF-prolyl hydroxylase inhibitors on VEGF expression and vascular adverse events in chronic kidney disease: a meta-analysis of 34 randomized controlled trialsSeyed Mahdi Montazer, Amirali Asadi, Amirali Taghipour, et al.Journal of Nephrology|July 28, 2026
Efficacy and safety of finerenone with or without combination therapy in patients with non-diabetic chronic kidney disease: a real-world observational studyYanli Fang, Yun Shao, Xinyi Lin, et al.Pageof 396